https://www.selleckchem.com/products/AZD8931.html
In the skin areas, the doses were as follows 1-2cm from the applicator, 1.86±0.77Gy; 2-5cm, 0.73±0.14Gy; andgreater than5cm, 0.28±0.17Gy. The dose delivered to the pectoral muscle (tungsten shielding disc) was 0.51±0.27Gy. The study demonstrated the viability of XR-RV3 films for in vivo dose measurement in the dose and energy ranges applied in a complex procedure, such as breast IORT. The doses in organs at risk were far below the tolerances for cases such as those studied. The study demonstrated the viability of XR-RV3 films for in viv
Like
Comment
Share
